12 results
The objective of this trial is to investigate whether Eltrombopag added to standard immunosuppressive treatment increases the rate of early (at three months) complete response and blood counts and can be use as front-line therapy for SAA treatment.
The objective is to investigate the effect of strenuous exercise (participation to the Amstel Gold Race) on coagulation and haemostatic parameters.
Objective: The primary objective of this pilot study is to compare FDG-PET-CT with HR-CT alone and to HR-CT and galactomannan test together for early diagnosing IFIs in neutropenic patients.
1. To establish whether serial exhaled breath analysis using eNose can detect invasive pulmonary aspergillosis in patients with prolonged chemotherapy induced neutropenia (neutrophil counts <0.5 x 10^9 for more than 7 days).2. To establish…
Evaluation of acute joint damage immediately after a joint bleed in patients with haemophilia, by use of a panel of state-of-the-art biomarkers of cartilage and bone turnover measured in blood and urine. The question that will be addressed is…
In this study, we will investigate the use of optical spectroscopy in determining neonatal bilirubin and hemoglobin blood levels. The outcome and accuracy of the optical spectroscopy measurements will be compared to the outcome of laboratory blood…
to establish the accuracy with which the eNose can discriminate patients with invasive pulmonary aspergillosis from controls
To demonstrate the accuracy of FLT-PET to be an early response parameter for haematological recovery.
Primary Objective: The main goal of this project is to identify CVR predictors including CBF, age, sex and vascular stressors in anaemic and control patients using several MRI techniques. While anaemia is correlated with other cerebrovascular risk…
We aim to validate the TSAT/hepcidin ratio as a diagnostic tool with a high specificity and to establish a cut off point in order to discriminate between Iron Refractory Iron Deficiency Anemia (IRIDA) and iron deficiency anemia (IDA) not because of…
The Biobank 'Leukemia, Myeloma, Lymphoma and Myelofibrosis' has the scientific objective of gaining insight in molecular-biological and environmental factors, that are involved in the development of malignant hematological diseases such as…
To determine the clinical utility of sequential computational assisted CT-guided treatment of PFI in the hemato-oncology population.